James Peyer - 28 Feb 2022 Form 4 Insider Report for Sensei Biotherapeutics, Inc. (SNSE)

Role
Director, 10%+ Owner
Signature
/s/ Sarah Field, Attorney-in-Fact
Issuer symbol
SNSE
Transactions as of
28 Feb 2022
Net transactions value
+$9,000
Form type
4
Filing time
01 Mar 2022, 17:55:44 UTC
Previous filing
28 Feb 2022
Next filing
10 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNSE Common Stock Purchase $151 +42 +0% $3.60 5,228,328 28 Feb 2022 See Footnote F1
transaction SNSE Common Stock Purchase $8,849 +2,458 +0.05% $3.60 5,230,786 01 Mar 2022 See Footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held by Cambrian Biopharma Inc, a Delaware corporation ("Cambrian"). The Reporting Person is the Chief Executive Officer of Cambrian and in such capacity may direct the voting and disposition of the shares held by Cambrian, subject in certain instances to the approval of Cambrian's Board of Directors. Mr. Peyer disclaims beneficial ownership of such shares.